• Zivo Bioscience common stock transitioned to quotation on OTCID marketplace under ticker ZIVO.
• Trading on OTCID began Monday, May 11, 2026.
• Company will continue publishing corporate and financial information through its OTC Markets disclosure page.
• Existing shareholders retain their positions through transition, with no action required.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zivo Bioscience Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605121009BIZWIRE_USPR_____20260512_BW411739) on May 12, 2026, and is solely responsible for the information contained therein.